Integrated Evidence Generation (IEG) Lead
Remote within Europe
The Company
The Menarini Group is a global health care organization with a diversified portfolio of prescription and non‑prescription medicines, medical devices and in vitro diagnostics. The Global R&D organization of the Menarini Group is currently building a new pipeline of innovative compounds that will help to address unmet medical needs and improve patients’ lives.
The Menarini Group is present in 140 countries worldwide with over 17,500 employees. High quality therapeutics and diagnostics solutions for patients, ethics as our underlying principle, dedication to innovation and advancement, strong people centricity and environmental sustainability. These pillars form the foundation of the Menarini Group, an Italian pharmaceutical company with nearly 135 years of history.
More recently, Menarini has acquired Stemline Therapeutics, strengthening its oncology portfolio with the addition of both commercial and clinical‑stage assets. The acquisition of Stemline established Menarini’s presence in the US biopharmaceutical oncology market, where the Company will enable global expansion by leveraging its commercial infrastructure in Europe and other ex‑US geographies.
We are seeking a highly skilled and strategically minded Associate Director, Integrated Evidence Generation (IEG) Lead to strengthen our Real‑World Evidence (RWE) capabilities. This remote role (Europe‑based) will support the Primary Care therapeutic area and will play a pivotal part in shaping and driving our integrated evidence strategy across the product lifecycle.
The IEG Lead will coordinate cross‑functional evidence planning, provide methodological leadership for RWE studies, and ensure that real‑world data and evidence are generated, communicated, and utilized in a scientifically robust and business‑relevant manner. This is an exciting opportunity to work at the interface of Medical, Clinical Development, Market Access, HEOR, and Regulatory.
Key Responsibilities
* Lead the Integrated Evidence Generation (IEG) planning process for Primary Care, ensuring alignment across Medical Affairs, Clinical Development, Market Access, HEOR, Regulatory and countries
* Translate strategic needs into actionable evidence plans that support launch excellence and long‑term positioning.
* Drive prioritization, sequencing, and cross‑functional alignment of evidence activities.
* Ideate, design, and oversee the delivery of fit‑for‑purpose RWE studies, including unmet need analysis, treatment patterns, comparative effectiveness analyses, predictive modeling, and prospective/retrospective observational studies.
* Serve as the methodological lead for RWE questions in the Primary Care space, ensuring scientific rigor and fit‑for‑purpose study designs.
* Evaluate, select, and steer external partnerships (CROs, academic groups, data vendors) as well as shape and evolve the Primary Care RWD/E strategy.
* Ensure optimal use of available real‑world datasets to support key scientific, clinical, and commercial decision‑making.
* Partner closely with Market Access, Medical Affairs, HEOR, Clinical Development, Safety, Regulatory and key countries to ensure that evidence generation is cohesive, integrated, and strategically meaningful.
* Lead training initiatives to elevate real‑world evidence literacy across the primary care organization and promote best practices and methodological excellence for evidence generation.
Minimum Qualifications
* Master’s degree or higher in Epidemiology, Pharmacoepidemiology, Biostatistics, Public Health, Data Science, or related quantitative disciplines.
* 8+ years of experience in RWE, pharmacoepidemiology, or integrated evidence generation within the pharmaceutical industry or consulting.
* Proven track record in designing and leading RWE studies using RWD sources (e.g., EHR, claims, registries, digital health data).
* Expert understanding of observational research design, causal inference, and real‑world study operationalization.
* Experience engaging with cross‑functional teams in a global, matrixed environment.
* Excellent communication skills with the ability to translate complex methods and results into strategic insights for diverse stakeholders.
* Strong project leadership skills with the ability to drive evidence plans from concept to execution.
Preferred Qualifications
* Experience in cardiometabolic, cardiovascular, or lipid disorders is a strong advantage.
* Familiarity with evidence needs for HTA submissions, including the role of RWE in clinical trial contextualization and external control arm methodologies.
* Prior involvement in IEG planning, evidence roadmaps, or launch‑related evidence generation.
* Publication record and experience presenting at scientific conferences.
* Experience mentoring junior colleagues and contributing to organizational capability building.
Menarini Group is an equal‑opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
#J-18808-Ljbffr